India approves its first dengue vaccine QDENGA after DCGI clearance
Dengue is a mosquito-borne viral disease reported in more than 125 countries. According to the company, India accounts for nearly one-third of the global dengue burden, with rapid urbanisation, climate change and widespread mosquito breeding continuing to increase the risk of infection across the country. Vaccine QDENGA is given as two injections of 0.5 ml, administered under the skin three months apart.
This summary was generated by PolitGlobe's AI pipeline from publicly available reporting at Times of India. For the full original article, visit the source below.
Read full article at Times of IndiaRelated coverage
Trump imposes 50% US tariffs on some Canadian goods, citing discrimination
Tariffs apply to Canadian wine, hockey sticks, cement, and other products, sparking fears of escalating trade tensions.
Iran war live: US launches 10th night of strikes; Tehran attacks Kuwait
Explosions reported in Iran's Bandar Abbas, Qeshm Island, Chabahar and Konarak as US launches new wave of attacks.
MSF demands Israel release detained Palestinian healthcare workers
The NGO is 'outraged' by Israel's treatment of the health professionals and warns that 'silence has become complicity'.
Suspect charged in fatal attack on UK politician Ann Widdecombe
Police say a possible political motive is under investigation in the killing of the Reform UK figure.